JP6530165B2 - 分析方法 - Google Patents
分析方法 Download PDFInfo
- Publication number
- JP6530165B2 JP6530165B2 JP2014118850A JP2014118850A JP6530165B2 JP 6530165 B2 JP6530165 B2 JP 6530165B2 JP 2014118850 A JP2014118850 A JP 2014118850A JP 2014118850 A JP2014118850 A JP 2014118850A JP 6530165 B2 JP6530165 B2 JP 6530165B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- tape
- adhesive tape
- keratinocytes
- external preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004458 analytical method Methods 0.000 title claims description 16
- 210000003491 skin Anatomy 0.000 claims description 65
- 150000002500 ions Chemical class 0.000 claims description 53
- 210000002510 keratinocyte Anatomy 0.000 claims description 35
- 239000002390 adhesive tape Substances 0.000 claims description 33
- 238000002360 preparation method Methods 0.000 claims description 27
- 210000000434 stratum corneum Anatomy 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 20
- 238000005011 time of flight secondary ion mass spectroscopy Methods 0.000 claims description 20
- 238000013507 mapping Methods 0.000 claims description 15
- 102000011782 Keratins Human genes 0.000 claims description 7
- 108010076876 Keratins Proteins 0.000 claims description 7
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 description 17
- 229910052708 sodium Inorganic materials 0.000 description 12
- 239000011734 sodium Substances 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 10
- -1 ascorbyl magnesium phosphate Chemical compound 0.000 description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 8
- 239000004137 magnesium phosphate Substances 0.000 description 8
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 8
- 229960002261 magnesium phosphate Drugs 0.000 description 8
- 235000010994 magnesium phosphates Nutrition 0.000 description 8
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 8
- 238000005259 measurement Methods 0.000 description 7
- 229920000742 Cotton Polymers 0.000 description 6
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000035699 permeability Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 239000010931 gold Substances 0.000 description 4
- 238000004299 exfoliation Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- HZZOEADXZLYIHG-UHFFFAOYSA-N magnesiomagnesium Chemical compound [Mg][Mg] HZZOEADXZLYIHG-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 238000002042 time-of-flight secondary ion mass spectrometry Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
(試料の塗布及び角質細胞の剥離)
被験者の前腕内側部2.5cm×3.5cmに1%リン酸アスコルビルマグネシウムを含む水溶液2mLを含浸させたコットンを貼付し、5分間静置した。コットンを取り除いた後、新しいコットンで皮膚表面に残った試料を取り除き、5分間静置した。その後、塗布部位よりメンディングテープ(住友3M)を用いて、連続7回テープストリップをして、角質細胞を剥離し、得られたテープを標本とした。コントロールは、隣接部位にリン酸アスコルビルマグネシウムを含まない製剤を用いて同じ実験を行った。
7層分の角質細胞を剥離した7枚の粘着テープを標本とし、TOF−SIMSにより分析を行った。検出条件を以下に示す。
(1)装置:TRIFT−III(アルバックファイ社製)
(2)測定条件:
高分解能イメージングモード
1次イオン 197Au1+ :22kV(current:1.2nA、Pulse width 11ns)
検出:Positive
測定範囲:300×300μm2、256×256pixel、20分積算
(試料の塗布及び角質細胞の剥離)
被験者の前腕内側部2.5cm×3.5cmに0.5%トコフェリルリン酸ナトリウムを含む水溶液2mLを含浸させたコットンを貼付し、5分間静置した。コットンを取り除いた後、新しいコットンで皮膚表面に残った試料を取り除き、60分間静置した。その後、塗布部位よりメンディングテープ(住友3M)を用いて、連続7回テープストリップをして、角質細胞を剥離し、得られたテープを標本とした。コントロールは、隣接部位にトコフェリルリン酸ナトリウムを含まない製剤を用いて同じ実験を行った。
7層分の角質細胞を剥離した7枚の粘着テープを標本とし、TOF−SIMSにより分析を行った。検出条件を以下に示す。
(1)装置:TRIFT−III(アルバックファイ社製)
(2)測定条件:
高分解能イメージングモード
1次イオン 197Au1+ :22kV(current:1.2nA、Pulse width 11ns)
検出:Negative
測定範囲:300×300μm2、256×256pixel、20分積算
Claims (1)
- 皮膚に浸透した皮膚外用剤の成分の量と分布を分析する方法であって、
皮膚外用剤を皮膚に塗布する工程と、
皮膚外用剤が塗布された該皮膚の領域から粘着テープを用いて複数層の角質を剥離する工程と、
TOF−SIMSを用いて、該角質が付着した粘着テープから生成したイオンを質量分析する工程と、
角質が付着した粘着テープから生成したイオンの分布を平面上にマッピングする工程とを有することを特徴とし、
平面上にマッピングする角質が付着した粘着テープから生成したイオンが、皮膚に塗布した皮膚外用剤の成分、角質細胞及びテープのイオンのみである分析方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014118850A JP6530165B2 (ja) | 2014-06-09 | 2014-06-09 | 分析方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014118850A JP6530165B2 (ja) | 2014-06-09 | 2014-06-09 | 分析方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015232462A JP2015232462A (ja) | 2015-12-24 |
JP6530165B2 true JP6530165B2 (ja) | 2019-06-12 |
Family
ID=54933999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014118850A Active JP6530165B2 (ja) | 2014-06-09 | 2014-06-09 | 分析方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6530165B2 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102587336B1 (ko) * | 2016-08-09 | 2023-10-12 | (주)아모레퍼시픽 | 화장료 조성물들의 동일성 판별 방법 |
KR102101484B1 (ko) * | 2018-09-07 | 2020-04-16 | 한국과학기술연구원 | 이차이온 질량분석기 및 주성분 분석을 이용한 흔적증거물 감식방법 |
CN112229699B (zh) * | 2020-09-27 | 2023-01-13 | 胜科纳米(苏州)股份有限公司 | 一种用于动态二次离子质谱(d-sims)分析的样品制备方法 |
JP7554465B2 (ja) | 2020-10-30 | 2024-09-20 | 国立大学法人福島大学 | イメージング質量分析用薄切片の作製方法、及び生体表面における対象物質の局在解析方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102388304B (zh) * | 2009-04-10 | 2014-03-12 | 佳能株式会社 | 形成质量图像的方法 |
US8420054B2 (en) * | 2009-09-18 | 2013-04-16 | The Procter & Gamble Company | Noninvasive method for measuring histamine from skin as an objective measurement of itch |
JP5676319B2 (ja) * | 2010-04-07 | 2015-02-25 | 富士フイルム株式会社 | 水性化粧料の製造方法 |
JP5970246B2 (ja) * | 2011-06-07 | 2016-08-17 | 株式会社 資生堂 | 分析方法及び分析キット |
JP6006548B2 (ja) * | 2012-07-04 | 2016-10-12 | 株式会社 資生堂 | 成分分布可視化装置、成分分布可視化方法、及び成分分布可視化プログラム |
-
2014
- 2014-06-09 JP JP2014118850A patent/JP6530165B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2015232462A (ja) | 2015-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6530165B2 (ja) | 分析方法 | |
Mavon et al. | In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen | |
Al-Mayahy et al. | Insight into imiquimod skin permeation and increased delivery using microneedle pre-treatment | |
Girod et al. | Composition of fingermark residue: a qualitative and quantitative review | |
Choe et al. | Analysis of human and porcine skin in vivo/ex vivo for penetration of selected oils by confocal Raman microscopy | |
Karimi-Maleh et al. | Simultaneous determination of 6-mercaptopruine, 6-thioguanine and dasatinib as three important anticancer drugs using nanostructure voltammetric sensor employing Pt/MWCNTs and 1-butyl-3-methylimidazolium hexafluoro phosphate | |
Pudney et al. | An in vivo confocal Raman study of the delivery of trans retinol to the skin | |
Franquelo et al. | XRF, μ-XRD and μ-spectroscopic techniques for revealing the composition and structure of paint layers on polychrome sculptures after multiple restorations | |
Akomeah et al. | Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties | |
Chouhan et al. | Hydration of nail plate: a novel screening model for transungual drug permeation enhancers | |
Čižinauskas et al. | Fatty acids penetration into human skin ex vivo: A TOF-SIMS analysis approach | |
EP2565637A3 (en) | Electrochemical analyte measurement method and system | |
Grice et al. | Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitro | |
Kezutyte et al. | Studying the penetration of fatty acids into human skin by ex vivo TOF-SIMS imaging | |
Lekki et al. | On the follicular pathway of percutaneous uptake of nanoparticles: Ion microscopy and autoradiography studies | |
Adlhart et al. | Surface distribution and depths profiling of particulate organic UV absorbers by Raman imaging and tape stripping | |
Salocks et al. | Dermal exposure to methamphetamine hydrochloride contaminated residential surfaces: surface pH values, volatility, and in vitro human skin | |
Stucky et al. | Improved serotonin measurement with fast-scan cyclic voltammetry: Mitigating fouling by SSRIs | |
Karimi et al. | Rapid analysis of captopril in human plasma and pharmaceutical preparations by headspace solid phase microextraction based on polypyrrole film coupled to ion mobility spectrometry | |
Cullander et al. | A quantitative minimally invasive assay for the detection of metals in the stratum corneum | |
Hsieh et al. | Visualization of first-pass drug metabolism of terfenadine by MALDIImaging mass spectrometry | |
Nicolau et al. | Deposition of viprostol (a synthetic PGE2 vasodilator) in the skin following topical administration to laboratory animals | |
Prideaux et al. | Applications of MALDI-MSI to pharmaceutical research | |
Berko et al. | Monitoring of skin penetration and absorption with a new in vivo experimental model | |
Forslind et al. | Recent advances in X-ray microanalysis in dermatology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170516 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180426 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180515 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180628 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181120 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181228 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190514 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190516 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6530165 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |